Cost-effectiveness of interventions for HIV/AIDS, malaria, syphilis, and tuberculosis in 128 countries: a meta-regression analysis-Reference-Cited by-同舟云学术

Cost-effectiveness of interventions for HIV/AIDS, malaria, syphilis, and tuberculosis in 128 countries: a meta-regression analysis

Published:2024-07 Issue:7 Volume:12 Page:e1159-e1173
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Silke Fiona,Earl Lauren,Hsu Johnathan,Janko Mark M,Joffe Jonah,Memetova Aishe,Michael Danielle,Zheng Peng,Aravkin Aleksandr,Murray Christopher J L,Weaver Marcia R

Funder

Bill & Melinda Gates Foundation

Publisher

Elsevier BV

Reference29 articles.

1. Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019;Lancet HIV,2021

2. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019;Lancet Infect Dis,2022

3. Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study;Weiss;Lancet,2019

4. Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study;Battle;Lancet,2019

5. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3;Micah;Lancet,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aligning meta-regression analyses of cost-effectiveness evidence to policy makers' needs;The Lancet Global Health;2024-07